Biotech · Private company · Pasadena, CA, US
Acurastem, Inc.
Track this companyFree. Adds Acurastem, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of a SYF2 antisense oligonucleotide treatment for ALS and FTDFiscal year 2024 · $1.4MNIH RePORTER 5R44AG085411-02 · fetched Nov 12, 2026
- Development of an UNC13A antisense oligonucleotide treatment for ALS and FTDFiscal year 2024 · $1.3MNIH RePORTER 5R44NS132698-02 · fetched Nov 12, 2026